Parallel evolution leading to impaired biofilm formation in invasive Salmonella strains.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
06 2019
Historique:
received: 21 02 2019
accepted: 07 06 2019
revised: 05 07 2019
pubmed: 25 6 2019
medline: 7 11 2019
entrez: 25 6 2019
Statut: epublish

Résumé

Pathogenic Salmonella strains that cause gastroenteritis are able to colonize and replicate within the intestines of multiple host species. In general, these strains have retained an ability to form the rdar morphotype, a resistant biofilm physiology hypothesized to be important for Salmonella transmission. In contrast, Salmonella strains that are host-adapted or even host-restricted like Salmonella enterica serovar Typhi, tend to cause systemic infections and have lost the ability to form the rdar morphotype. Here, we investigated the rdar morphotype and CsgD-regulated biofilm formation in two non-typhoidal Salmonella (NTS) strains that caused invasive disease in Malawian children, S. Typhimurium D23580 and S. Enteritidis D7795, and compared them to a panel of NTS strains associated with gastroenteritis, as well as S. Typhi strains. Sequence comparisons combined with luciferase reporter technology identified key SNPs in the promoter region of csgD that either shut off biofilm formation completely (D7795) or reduced transcription of this key biofilm regulator (D23580). Phylogenetic analysis showed that these SNPs are conserved throughout the African clades of invasive isolates, dating as far back as 80 years ago. S. Typhi isolates were negative for the rdar morphotype due to truncation of eight amino acids from the C-terminus of CsgD. We present new evidence in support of parallel evolution between lineages of nontyphoidal Salmonella associated with invasive disease in Africa and the archetypal host-restricted invasive serovar; S. Typhi. We hypothesize that the African invasive isolates are becoming human-adapted and 'niche specialized' with less reliance on environmental survival, as compared to gastroenteritis-causing isolates.

Identifiants

pubmed: 31233504
doi: 10.1371/journal.pgen.1008233
pii: PGENETICS-D-19-00304
pmc: PMC6611641
doi:

Substances chimiques

Trans-Activators 0

Banques de données

figshare
['10.6084/m9.figshare.8220866.v1']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008233

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Appl Environ Microbiol. 2003 Jul;69(7):3687-94
pubmed: 12839733
Structure. 2011 Sep 7;19(9):1307-16
pubmed: 21893289
Nucleic Acids Res. 2013 Jan;41(Database issue):D666-75
pubmed: 23180763
J Bacteriol. 2006 Dec;188(24):8395-406
pubmed: 17012381
Front Microbiol. 2013 Nov 14;4:331
pubmed: 24294212
Appl Environ Microbiol. 2016 Jul 29;82(16):4931-43
pubmed: 27260360
J Med Microbiol. 2006 May;55(Pt 5):585-91
pubmed: 16585646
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3982-7
pubmed: 19234126
Infect Immun. 2018 Oct 25;86(11):
pubmed: 30150258
Appl Environ Microbiol. 2001 Sep;67(9):4048-56
pubmed: 11526004
Emerg Infect Dis. 2015 Jun;21(6):
pubmed: 25860298
Genome Res. 2009 Dec;19(12):2279-87
pubmed: 19901036
J Bacteriol. 2019 Jun 21;201(14):
pubmed: 30962351
J Bacteriol. 2006 Nov;188(22):7722-30
pubmed: 17079680
Pathog Dis. 2016 Jul;74(5):
pubmed: 27222487
FEMS Microbiol Lett. 2010 Nov;312(2):160-8
pubmed: 20874755
Infect Immun. 2008 Mar;76(3):1048-58
pubmed: 18195033
PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2487
pubmed: 24130915
mBio. 2014 Mar 18;5(2):e00929-14
pubmed: 24643865
Annu Rev Microbiol. 2006;60:131-47
pubmed: 16704339
Mol Microbiol. 2005 Dec;58(5):1322-39
pubmed: 16313619
PLoS One. 2011;6(12):e28351
pubmed: 22164276
J Bacteriol. 2010 Jun;192(12):2981-90
pubmed: 20118264
Environ Microbiol. 2011 Oct;13(10):2702-16
pubmed: 21883790
Clin Infect Dis. 2015 Nov 1;61 Suppl 4:S317-24
pubmed: 26449947
PLoS Negl Trop Dis. 2015 Mar 24;9(3):e0003611
pubmed: 25803844
Environ Microbiol. 2010 Jan;12(1):40-53
pubmed: 19691499
J Bacteriol. 1998 Feb;180(3):722-31
pubmed: 9457880
Nature. 2010 Sep 23;467(7314):426-9
pubmed: 20864996
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5183-8
pubmed: 25848006
Annu Rev Microbiol. 2008;62:193-210
pubmed: 18537474
Mol Microbiol. 2003 Aug;49(3):639-54
pubmed: 12864849
Mol Microbiol. 1995 Nov;18(4):661-70
pubmed: 8817489
J Bacteriol. 2019 Aug 22;201(18):
pubmed: 30936374
J Bacteriol. 2003 Sep;185(18):5398-407
pubmed: 12949092
Nat Genet. 2012 Nov;44(11):1215-21
pubmed: 23023330
Infect Immun. 2015 Feb;83(2):693-701
pubmed: 25422268
mBio. 2016 Mar 01;7(2):e02265
pubmed: 26933058
J Mol Biol. 1996 Oct 11;262(5):615-28
pubmed: 8876642
Biomolecules. 2017 Oct 31;7(4):
pubmed: 29088115
Cell Rep. 2018 Oct 23;25(4):825-832.e5
pubmed: 30355489
Nat Microbiol. 2018 May;3(5):563-569
pubmed: 29693659
Infect Immun. 2012 Dec;80(12):4398-408
pubmed: 23027540
Infect Immun. 2013 Feb;81(2):478-86
pubmed: 23208603
Lancet. 2012 Jun 30;379(9835):2489-2499
pubmed: 22587967
J Bacteriol. 1991 Aug;173(15):4773-81
pubmed: 1677357
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4353-8
pubmed: 20176950
Science. 2018 Jan 19;359(6373):334-338
pubmed: 29348238
Mol Microbiol. 2002 Feb;43(3):793-808
pubmed: 11929533
J Bacteriol. 2010 Jan;192(2):456-66
pubmed: 19897646
Appl Environ Microbiol. 2011 Jun;77(12):4136-46
pubmed: 21515723
Proc Natl Acad Sci U S A. 1990 Oct;87(20):8130-4
pubmed: 2146681
Mol Microbiol. 2001 Mar;39(6):1452-63
pubmed: 11260463
Mol Microbiol. 2005 Oct;58(1):289-304
pubmed: 16164566
Protein Sci. 2017 Oct;26(10):2073-2082
pubmed: 28758290
Annu Rev Microbiol. 2014;68:317-36
pubmed: 25208300
BMC Genomics. 2009 Jan 21;10:36
pubmed: 19159446
Bioinformatics. 2012 Jun 15;28(12):1647-9
pubmed: 22543367
Nat Rev Microbiol. 2015 Aug;13(8):497-508
pubmed: 26145732
Pathog Dis. 2015 Jun;73(4):
pubmed: 25808600
Nat Genet. 2008 Aug;40(8):987-93
pubmed: 18660809
Cell Microbiol. 2010 Oct;12(10):1495-505
pubmed: 20497180
Nat Genet. 2016 Oct;48(10):1211-1217
pubmed: 27548315
Nature. 2001 Oct 25;413(6858):848-52
pubmed: 11677608
Appl Environ Microbiol. 2005 Mar;71(3):1163-8
pubmed: 15746314
J Bacteriol. 2006 May;188(9):3219-27
pubmed: 16621814
Cold Spring Harb Perspect Med. 2013 Dec 01;3(12):a010041
pubmed: 24296346
Int J Med Microbiol. 2003 Aug;293(4):273-85
pubmed: 14503792
Clin Infect Dis. 2010 Mar 15;50(6):882-9
pubmed: 20158401
Lancet Infect Dis. 2010 Jun;10(6):417-32
pubmed: 20510282
Front Vet Sci. 2017 Aug 25;4:138
pubmed: 29159172
Trends Microbiol. 2015 Sep;23(9):545-57
pubmed: 26077867
Trends Microbiol. 2014 Nov;22(11):648-55
pubmed: 25065707
Infect Immun. 2013 Mar;81(3):653-64
pubmed: 23230292
J Bacteriol. 2007 Nov;189(22):8034-43
pubmed: 17873038
Nat Genet. 2015 Jun;47(6):632-9
pubmed: 25961941
Microbiol Spectr. 2017 Oct;5(5):
pubmed: 29027519
Curr Opin Microbiol. 2012 Feb;15(1):108-14
pubmed: 22030447
Infect Immun. 2008 Jan;76(1):403-16
pubmed: 17967858
Philos Trans R Soc Lond B Biol Sci. 2006 Nov 29;361(1475):1929-40
pubmed: 17062412
PLoS Genet. 2009 Dec;5(12):e1000779
pubmed: 20041030
Nat Rev Genet. 2013 Nov;14(11):751-64
pubmed: 24105273
Infect Immun. 2015 Jun;83(6):2312-26
pubmed: 25824832
PLoS Biol. 2006 Apr;4(4):e45
pubmed: 16602820
PLoS Negl Trop Dis. 2015 Jun 19;9(6):e0003839
pubmed: 26091096
Mol Microbiol. 2010 Aug;77(3):771-86
pubmed: 20545866
Nat Microbiol. 2016 Mar;1(3):
pubmed: 27127642
Microbiology. 2010 Aug;156(Pt 8):2470-2483
pubmed: 20466769
PLoS Med. 2015 Dec 03;12(12):e1001921
pubmed: 26633831
J Mol Biol. 2018 Sep 14;430(18 Pt B):3170-3189
pubmed: 30017920
Mol Microbiol. 1998 Apr;28(2):249-64
pubmed: 9622351
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2614-E2623
pubmed: 29487214
Curr Opin Infect Dis. 2017 Oct;30(5):498-503
pubmed: 28731899

Auteurs

Keith D MacKenzie (KD)

Vaccine and Infectious Disease Organization-International Vaccine Centre, Saskatoon, SK., Canada.
Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK., Canada.

Yejun Wang (Y)

Department of Cell Biology and Genetics, Shenzhen University Health Science Center, Guangdong, China.

Patrick Musicha (P)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Malawi Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Elizabeth G Hansen (EG)

Vaccine and Infectious Disease Organization-International Vaccine Centre, Saskatoon, SK., Canada.
Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK., Canada.

Melissa B Palmer (MB)

Vaccine and Infectious Disease Organization-International Vaccine Centre, Saskatoon, SK., Canada.
Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK., Canada.

Dakoda J Herman (DJ)

Vaccine and Infectious Disease Organization-International Vaccine Centre, Saskatoon, SK., Canada.
Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK., Canada.

Nicholas A Feasey (NA)

Malawi Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Aaron P White (AP)

Vaccine and Infectious Disease Organization-International Vaccine Centre, Saskatoon, SK., Canada.
Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK., Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH